The latest update is out from Medtronic ( (MDT) ).
On March 12, 2025, Jennifer M. Kirk, Medtronic’s Global Controller and Principal Accounting Officer, announced her resignation effective May 2, 2025, to become CEO of Exubrion Therapeutics. Denise L. Blomquist, with a 21-year tenure at Medtronic, will succeed her starting March 17, 2025, ensuring a smooth transition and continuity in the company’s financial leadership.
More about Medtronic
Medtronic plc operates in the medical technology industry, providing a wide range of products and services aimed at improving patient outcomes. The company focuses on innovative solutions for healthcare, including medical devices and therapies.
YTD Price Performance: 16.02%
Average Trading Volume: 7,181,289
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $119.4B
For an in-depth examination of MDT stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com